Skip to NavigationSkip to content

Features

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, 2016...

Ben Hargreaves looks at the pricing debate occurring within Europe and how it could lead to closer relations between countries within the EU.

Dr Dilruwan Chaminda Herath discusses whether the lack of impetus to push for recruitment of individuals with good clinical trials practice could...

President Trump's pledge to slash regulation in the pharma sector by 75% has already drawn concern from industry figures; what effects could his...

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in...

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark Brewer deconstruct what...

Last year, Pfizer was fined a record sum for overcharging the NHS by exploiting regulation to hike the price of its drug Epanutin by 2,600%. Dr...

We arranged the top five European countries by the levels of expenditure upon pharmaceuticals, not all are from the largest countries and there's...

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new challenges...

With us rapidly moving into 2017, we took the chance to speak to four industry heads about their take on 2016m, featuring comment from AbbVie,...